Cargando…

Comparison of Ventricular Inducibility with Late Gadolinium Enhancement and Myocardial Inflammation in Endomyocardial Biopsy in Patients with Dilated Cardiomyopathy

BACKGROUND: Risk stratification of patients with non-ischemic dilated cardiomyopathy remains a matter of debate in the era of device implantation. OBJECTIVE: We investigated associations between histopathological findings, contrast-enhanced cardiac MRI and the inducibility of ventricular tachycardia...

Descripción completa

Detalles Bibliográficos
Autores principales: Mueller, Karin A. L., Heck, Christian, Heinzmann, David, Schwille, Johannes, Klingel, Karin, Kandolf, Reinhard, Kramer, Ulrich, Gramlich, Michael, Geisler, Tobias, Gawaz, Meinrad P., Schreieck, Juergen, Seizer, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5145174/
https://www.ncbi.nlm.nih.gov/pubmed/27930686
http://dx.doi.org/10.1371/journal.pone.0167616
_version_ 1782473249476575232
author Mueller, Karin A. L.
Heck, Christian
Heinzmann, David
Schwille, Johannes
Klingel, Karin
Kandolf, Reinhard
Kramer, Ulrich
Gramlich, Michael
Geisler, Tobias
Gawaz, Meinrad P.
Schreieck, Juergen
Seizer, Peter
author_facet Mueller, Karin A. L.
Heck, Christian
Heinzmann, David
Schwille, Johannes
Klingel, Karin
Kandolf, Reinhard
Kramer, Ulrich
Gramlich, Michael
Geisler, Tobias
Gawaz, Meinrad P.
Schreieck, Juergen
Seizer, Peter
author_sort Mueller, Karin A. L.
collection PubMed
description BACKGROUND: Risk stratification of patients with non-ischemic dilated cardiomyopathy remains a matter of debate in the era of device implantation. OBJECTIVE: We investigated associations between histopathological findings, contrast-enhanced cardiac MRI and the inducibility of ventricular tachycardia (VT) or fibrillation (VF) in programmed ventricular stimulation. METHODS: 56 patients with impaired left ventricular ejection fraction (LVEF≤50%, mean 36.6±10.5%) due to non-ischemic dilated cardiomyopathy underwent cardiac MRI, programmed ventricular stimulation, and endomyocardial biopsy and were retrospectively investigated. Inducibility was defined as sustained mono- or polymorphic VT or unstable VT/VF requiring cardioversion/defibrillation. Primary study endpoint was defined as the occurrence of hemodynamically relevant VT/VF and/or adequate ICD-therapy during follow-up. RESULTS: Endomyocardial biopsy detected cardiac fibrosis in 18 (32.1%) patients. Cardiac MRI revealed 35 (62.5%) patients with positive late gadolinium enhancement. VT/VF was induced in ten (17.9%) patients during programmed ventricular stimulation. Monomorphic VT was inducible in 70%, while 20% of patients showed polymorphic VT. One patient (10%) presented with VF. Inducibility correlated significantly with the presence of positive late gadolinium enhancement in cardiac MRI (p<0.01). We could not find a significant association between inducibility and the degree of cardiac inflammation and fibrosis in non-site directed routine right ventricular endomyocardial biopsy. During a mean follow-up of 2.6 years, nine (16.1%) patients reached the primary endpoint. Monomorphic VTs were found in 66.7% patients and were terminated by antitachycardia pacing therapy. One patient with polymorphic VT and two patients with VF received adequate therapy by an ICD-shock. However, inducibility did not correlate with the occurrence of endpoints. CONCLUSION: Inducibilty during programmed ventricular stimulation is associated with positive late gadolinium enhancement in cardiac MRI of patients with non-ischemic dilated cardiomyopathy. The presence of myocardial fibrosis or inflammation in undirected endomyocardial biopsy does not seem to be sufficient to predict future ventricular arrhythmias.
format Online
Article
Text
id pubmed-5145174
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-51451742016-12-22 Comparison of Ventricular Inducibility with Late Gadolinium Enhancement and Myocardial Inflammation in Endomyocardial Biopsy in Patients with Dilated Cardiomyopathy Mueller, Karin A. L. Heck, Christian Heinzmann, David Schwille, Johannes Klingel, Karin Kandolf, Reinhard Kramer, Ulrich Gramlich, Michael Geisler, Tobias Gawaz, Meinrad P. Schreieck, Juergen Seizer, Peter PLoS One Research Article BACKGROUND: Risk stratification of patients with non-ischemic dilated cardiomyopathy remains a matter of debate in the era of device implantation. OBJECTIVE: We investigated associations between histopathological findings, contrast-enhanced cardiac MRI and the inducibility of ventricular tachycardia (VT) or fibrillation (VF) in programmed ventricular stimulation. METHODS: 56 patients with impaired left ventricular ejection fraction (LVEF≤50%, mean 36.6±10.5%) due to non-ischemic dilated cardiomyopathy underwent cardiac MRI, programmed ventricular stimulation, and endomyocardial biopsy and were retrospectively investigated. Inducibility was defined as sustained mono- or polymorphic VT or unstable VT/VF requiring cardioversion/defibrillation. Primary study endpoint was defined as the occurrence of hemodynamically relevant VT/VF and/or adequate ICD-therapy during follow-up. RESULTS: Endomyocardial biopsy detected cardiac fibrosis in 18 (32.1%) patients. Cardiac MRI revealed 35 (62.5%) patients with positive late gadolinium enhancement. VT/VF was induced in ten (17.9%) patients during programmed ventricular stimulation. Monomorphic VT was inducible in 70%, while 20% of patients showed polymorphic VT. One patient (10%) presented with VF. Inducibility correlated significantly with the presence of positive late gadolinium enhancement in cardiac MRI (p<0.01). We could not find a significant association between inducibility and the degree of cardiac inflammation and fibrosis in non-site directed routine right ventricular endomyocardial biopsy. During a mean follow-up of 2.6 years, nine (16.1%) patients reached the primary endpoint. Monomorphic VTs were found in 66.7% patients and were terminated by antitachycardia pacing therapy. One patient with polymorphic VT and two patients with VF received adequate therapy by an ICD-shock. However, inducibility did not correlate with the occurrence of endpoints. CONCLUSION: Inducibilty during programmed ventricular stimulation is associated with positive late gadolinium enhancement in cardiac MRI of patients with non-ischemic dilated cardiomyopathy. The presence of myocardial fibrosis or inflammation in undirected endomyocardial biopsy does not seem to be sufficient to predict future ventricular arrhythmias. Public Library of Science 2016-12-08 /pmc/articles/PMC5145174/ /pubmed/27930686 http://dx.doi.org/10.1371/journal.pone.0167616 Text en © 2016 Mueller et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Mueller, Karin A. L.
Heck, Christian
Heinzmann, David
Schwille, Johannes
Klingel, Karin
Kandolf, Reinhard
Kramer, Ulrich
Gramlich, Michael
Geisler, Tobias
Gawaz, Meinrad P.
Schreieck, Juergen
Seizer, Peter
Comparison of Ventricular Inducibility with Late Gadolinium Enhancement and Myocardial Inflammation in Endomyocardial Biopsy in Patients with Dilated Cardiomyopathy
title Comparison of Ventricular Inducibility with Late Gadolinium Enhancement and Myocardial Inflammation in Endomyocardial Biopsy in Patients with Dilated Cardiomyopathy
title_full Comparison of Ventricular Inducibility with Late Gadolinium Enhancement and Myocardial Inflammation in Endomyocardial Biopsy in Patients with Dilated Cardiomyopathy
title_fullStr Comparison of Ventricular Inducibility with Late Gadolinium Enhancement and Myocardial Inflammation in Endomyocardial Biopsy in Patients with Dilated Cardiomyopathy
title_full_unstemmed Comparison of Ventricular Inducibility with Late Gadolinium Enhancement and Myocardial Inflammation in Endomyocardial Biopsy in Patients with Dilated Cardiomyopathy
title_short Comparison of Ventricular Inducibility with Late Gadolinium Enhancement and Myocardial Inflammation in Endomyocardial Biopsy in Patients with Dilated Cardiomyopathy
title_sort comparison of ventricular inducibility with late gadolinium enhancement and myocardial inflammation in endomyocardial biopsy in patients with dilated cardiomyopathy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5145174/
https://www.ncbi.nlm.nih.gov/pubmed/27930686
http://dx.doi.org/10.1371/journal.pone.0167616
work_keys_str_mv AT muellerkarinal comparisonofventricularinducibilitywithlategadoliniumenhancementandmyocardialinflammationinendomyocardialbiopsyinpatientswithdilatedcardiomyopathy
AT heckchristian comparisonofventricularinducibilitywithlategadoliniumenhancementandmyocardialinflammationinendomyocardialbiopsyinpatientswithdilatedcardiomyopathy
AT heinzmanndavid comparisonofventricularinducibilitywithlategadoliniumenhancementandmyocardialinflammationinendomyocardialbiopsyinpatientswithdilatedcardiomyopathy
AT schwillejohannes comparisonofventricularinducibilitywithlategadoliniumenhancementandmyocardialinflammationinendomyocardialbiopsyinpatientswithdilatedcardiomyopathy
AT klingelkarin comparisonofventricularinducibilitywithlategadoliniumenhancementandmyocardialinflammationinendomyocardialbiopsyinpatientswithdilatedcardiomyopathy
AT kandolfreinhard comparisonofventricularinducibilitywithlategadoliniumenhancementandmyocardialinflammationinendomyocardialbiopsyinpatientswithdilatedcardiomyopathy
AT kramerulrich comparisonofventricularinducibilitywithlategadoliniumenhancementandmyocardialinflammationinendomyocardialbiopsyinpatientswithdilatedcardiomyopathy
AT gramlichmichael comparisonofventricularinducibilitywithlategadoliniumenhancementandmyocardialinflammationinendomyocardialbiopsyinpatientswithdilatedcardiomyopathy
AT geislertobias comparisonofventricularinducibilitywithlategadoliniumenhancementandmyocardialinflammationinendomyocardialbiopsyinpatientswithdilatedcardiomyopathy
AT gawazmeinradp comparisonofventricularinducibilitywithlategadoliniumenhancementandmyocardialinflammationinendomyocardialbiopsyinpatientswithdilatedcardiomyopathy
AT schreieckjuergen comparisonofventricularinducibilitywithlategadoliniumenhancementandmyocardialinflammationinendomyocardialbiopsyinpatientswithdilatedcardiomyopathy
AT seizerpeter comparisonofventricularinducibilitywithlategadoliniumenhancementandmyocardialinflammationinendomyocardialbiopsyinpatientswithdilatedcardiomyopathy